Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Plasma DNA and Vascular Remodelling in Patients With Sickle Cell Disease

NCT02721472 is registered in ClinicalTrials.gov with Theravia as lead sponsor.

NCT NCT02721472
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02721472 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Plasma DNA and Vascular Remodelling in Patients With Sickle Cell Disease
Lead sponsor
Theravia
Phase
Not applicable
Overall status
Completed
Start date
May 17, 2016
Completion date
November 14, 2019
Enrollment
44 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

sickle cell disease